| Aurobindo Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524804 |
NSE Symbol : AUROPHARMA |
P/E(TTM) : 47.17 |
|
ISIN Demat : INE406A01037 |
Div & Yield% : 0.29 |
EPS(TTM) : 32.62 |
|
Book Value(₹) : 336.60 |
Market Cap(₹Cr) : 90,161.30 |
Face Value(₹) : 1.00 |
| Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 |
| Reserves | 19,664.23 | 17,975.44 | 17,058.75 | 15,866.02 | 12,993.91 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 19,722.82 | 18,034.03 | 17,117.34 | 15,924.61 | 13,052.50 |
| Secured Loans | 1,431.99 | 1,922.78 | 288.75 | 841.50 | 1,314.36 |
| Unsecured Loans | 1,428.75 | 2,280.38 | 1,606.14 | 3,200.46 | 2,427.10 |
| Total Debt | 2,860.74 | 4,203.16 | 1,894.89 | 4,041.96 | 3,741.46 |
| Other Liabilities | 46.00 | 87.31 | 5.03 | 0.00 | 42.68 |
| Total Liabilities | 22,629.56 | 22,324.50 | 19,017.26 | 19,966.57 | 16,836.64 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 4,043.49 | 6,214.71 | 5,724.90 | 6,688.90 | 6,180.91 |
| Less: Accumulated Depreciation | 1,624.36 | 2,527.21 | 2,139.07 | 2,216.83 | 1,763.11 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 2,419.13 | 3,687.50 | 3,585.83 | 4,472.07 | 4,417.80 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 132.68 | 239.09 | 225.15 | 734.89 | 814.85 |
| Investments | 13,393.44 | 8,105.37 | 6,584.36 | 5,009.93 | 2,527.41 |
| Current Assets, Loans & Advances | |||||
| Inventories | 2,367.60 | 4,125.26 | 3,356.18 | 4,841.38 | 4,359.57 |
| Sundry Debtors | 3,776.59 | 4,560.26 | 3,973.24 | 5,928.01 | 5,785.00 |
| Cash and Bank Balance | 94.34 | 373.41 | 50.78 | 386.18 | 86.16 |
| Loans and Advances | 1,000.59 | 906.05 | 2,454.90 | 1,051.40 | 1,057.55 |
| Total Current Assets | 7,239.12 | 9,964.98 | 9,835.10 | 12,206.97 | 11,288.28 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 2,285.86 | 2,396.31 | 2,243.30 | 2,539.03 | 2,526.66 |
| Provisions | 119.65 | 122.09 | 103.36 | 250.01 | 115.27 |
| Total CL & Provisions | 2,405.51 | 2,518.40 | 2,346.66 | 2,789.04 | 2,641.93 |
| Net Current Assets | 4,833.61 | 7,446.58 | 7,488.44 | 9,417.93 | 8,646.35 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 47.45 | 55.24 | 43.82 | 68.61 | 411.92 |
| Deferred Tax Liability | 166.36 | 271.15 | 280.85 | 501.99 | 496.96 |
| Net Deferred Tax | -118.91 | -215.91 | -237.03 | -433.38 | -85.04 |
| Other Assets | 1,969.61 | 3,061.87 | 1,370.51 | 765.13 | 515.27 |
| Total Assets | 22,629.56 | 22,324.50 | 19,017.26 | 19,966.57 | 16,836.64 |
| Contingent Liabilities | 1,969.15 | 534.26 | 152.93 | 770.10 | 2,006.56 |